News from the BioCity Campus

Study on the challenges and opportunities of vocational training in the LifeScience industry

biosaxony is the all-Saxon association for biotechnology, medical technology and healthcare. The network bundles the strengths of all member companies and represents their interests in politics and the public. Tasks of the cluster include the initiation of projects between business and science, the provision of services and know-how as well as the presentation of regional competencies in order to support the value-adding expansion of these cross-sectional technologies and to strengthen the economic region of Saxony.

For the project "InnoVET CLOU - future cluster for innovative vocational training" we want to determine the need for training and further education in companies on behalf of SBG Dresden, record the perception of training content and organization and depict the current training situation. With your assessment you contribute to a better understanding of the training situation in your company. Where are the challenges and opportunities? Please also take part if your company has not explicitly dealt with the subject of training and further education. This perspective is also valuable for us. We are looking forward to your participation.

You can access the survey here


More about InnoVET:

Source: Study by biosaxony on behalf of SBG Dresden

previous news

SMWK: The white paper is intended to provide new impetus for strengthening research in Saxony

Saxon Ministry of Science starts a strategic process. Social or technological megatrends such as mobility or connectivity and digitization are not only the subject of research, research also goes through them. Strengths and weaknesses of the scientific landscape in Saxony should therefore be analyzed and highlighted.


MPI EVA: Modern humans have evolved more effective protection against oxidative stress

Researchers from the Max Planck Institute for Evolutionary Anthropology in Leipzig and the Karolinska Institutet in Sweden have studied a protein involved in protection against oxidative stress. They show that the variant of the protein found in modern humans is better at protecting against inflammation and vascular disease than the Neanderthal variant.